Company: PGEN
Filing Date: 2025-03-19
Form Type: 10-K
Source: 0001356090-25-000007
Chunk: 161

Company: PRECIGEN, INC.
Filing Date: 2025-03-19
Form: 10-K
Item: Item 12
Chunk 161
---
$— $2,129,207 $12 $(2,090,706)$38,513 

The accompanying notes are an integral part of these consolidated financial statements.

F-11

Precigen, Inc. and Subsidiaries

Consolidated Statements of Cash Flows

Years Ended December 31, 2024, 2023, and 2022 

(Amounts in thousands)202420232022Cash flows from operating activitiesNet (loss) income $(126,235)$(95,904)$28,317 Adjustments to reconcile net (loss) income to net cash used in operating activities:Depreciation and amortization4,526 6,668 10,765 (Loss) Gain on disposals of assets, net(2)(72)421 Impairment of goodwill7,409 10,390 482 Impairment of other noncurrent assets32,915 445 638 Gain on sale of discontinued operations— — (94,702)Gain on debt retirement— (60)(961)Loss on reclassification of cumulative foreign currency translation adjustments2,915 — — Amortization of premiums (discounts) on investments, net(883)(1,809)832 Equity in net income of affiliates— — (862)Stock-based compensation expense9,471 9,888 10,206 Shares issued as payment for services553 545 575 Provision for credit losses— — 944 Accretion of debt discount and amortization of deferred financing costs— 60 1,042 Deferred income taxes(1,795)(479)(150)Issuance cost related to Warrants 292 — — Other noncash items— 2 107 Changes in operating assets and liabilities:Receivables:Trade(24)76 (2,175)Other438 12,153 (11,338)Prepaid expenses and other981 748 2,630 Other assets120 129 (101)Accounts payable1,549 (2,421)379 Accrued compensation and benefits3,145 5,227 (37)Other accrued liabilities(1,827)782 (1,517)Deferred revenue196 484 (23,396)Lease liabilities(55)(107)(107)Other long-term liabilities— — (37)Indem